SAN BRUNO, Calif. Biocodex on Wednesday announced that it has enlisted the services of Morgan & Sampson USA to help manage its growth and distribution of the probiotics Florastor and Florastor Kids into the U.S.
“Our initial foray into U.S. markets was a conservative one, but Florastor has proven to be very well-received in this country, and we have enjoyed an impressive growth in sales, supported solely by our team of sales consultants,” stated Mary Berry, U.S. marketing manager for Biocodex.
MSUSA will act as a liaison with wholesale drug and pharmacy retailers nationally. ”By joining with MSUSA, we are able to expose Florastor to the widest retail audience within the U.S. market to ensure that consumers will be able to easily find the product,” commented Dan Harper, Biocodex national sales manager.
Florastor was first introduced into the U.S. market in 2003 and the pediatric line extension was launched in 2005. In that time, the brand has experienced 75 percent annual growth, the company stated, crediting that growth to increased awareness of the probiotic category and doctor recommendations.